Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000001073 | SCV000440750 | likely benign | Acyl-CoA dehydrogenase 9 deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000201519 | SCV001437357 | uncertain significance | not specified | 2020-09-23 | criteria provided, single submitter | clinical testing | Variant summary: ACAD9 c.-44_-41dupTAAG is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.039 in 280626 control chromosomes in the gnomAD database, including 475 homozygotes. The observed variant frequency is approximately 35 fold of the estimated maximal expected allele frequency for a pathogenic variant in ACAD9 causing Mitochondrial Complex I Deficiency, Nuclear Type 20 phenotype (0.0011), strongly suggesting that the variant is benign. c.-44_-41dupTAAG has been reported in the literature in one individual affected with Acyl-Coenzyme dehydrogenase 9 deficiency (He_2007). The report does not provide unequivocal conclusions about association of the variant with Mitochondrial Complex I Deficiency, Nuclear Type 20. He_2007 reports this variant results in a transcriptional defect from patients liver sample and 75% reduction of expression of a reporter gene. One ClinVar submitter (evaluation after 2014) cites the variant as likely benign. Although the allele frequency of this variant suggests it may be benign, the possibility of it being a common low-penetrant pathogenic variant cannot be ruled out. Therefore, this variant was classified as VUS-possibly benign. |
Labcorp Genetics |
RCV001515971 | SCV001724163 | benign | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000001073 | SCV001737179 | likely benign | Acyl-CoA dehydrogenase 9 deficiency | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001515971 | SCV001903705 | benign | not provided | 2018-10-05 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000001073 | SCV000021223 | pathogenic | Acyl-CoA dehydrogenase 9 deficiency | 2007-07-01 | flagged submission | literature only | |
Natera, |
RCV000001073 | SCV001461494 | benign | Acyl-CoA dehydrogenase 9 deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000201519 | SCV001741580 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001515971 | SCV001932621 | likely benign | not provided | no assertion criteria provided | clinical testing |